EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phosphatidylserine synthesis controls oncogenic B cell receptor signaling in B cell lymphoma

Jumpei Omi iD, Taiga Kato iD, Yohei Yoshihama iD, Koki Sawada iD, Nozomu Kono iD, Junken Aoki iD

Journal of Cell Biology · 2024

DOI: 10.1083/jcb.202212074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cell Biology, 2024. Verfasst von Jumpei Omi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Lymphoma, B-Cell, Phosphatidylserines, Receptors, Antigen, B-Cell. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Japan Science and Technology Agency Moonshot R&D Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cells harness lipid metabolism to promote their own survival. We screened 47 cancer cell lines for survival dependency on phosphatidylserine (PS) synthesis using a PS synthase 1 (PTDSS1) inhibitor and found that B cell lymphoma is highly dependent on PS. Inhibition of PTDSS1 in B cell lymphoma cells caused a reduction of PS and phosphatidylethanolamine levels and an increase of phosphoinositide levels. The resulting imbalance of the membrane phospholipidome lowered the activation threshold for B cell receptor (BCR), a B cell–specific survival mechanism. BCR hyperactivation led to aberrant elevation of downstream Ca2+ signaling and subsequent apoptotic cell death. In a mouse xenograft model, PTDSS1 inhibition efficiently suppressed tumor growth and prolonged survival. Our findings suggest that PS synthesis may be a critical vulnerability of malignant B cell lymphomas that can be targeted pharmacologically.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, B-CellPhosphatidylserinesReceptors, Antigen, B-CellAnimalsHumansMiceApoptosisSignal TransductionPhosphatidylinositolsNitrogenous Group TransferasesPhosphatidylethanolamines

Substanzen

PhosphatidylserinesReceptors, Antigen, B-CellPhosphatidylinositolsNitrogenous Group TransferasesphosphatidylethanolaminePhosphatidylethanolaminesphospholipid serine base exchange enzyme

Autor:innen und Institutionen

  • Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
  • Daiichi Sankyo Co., Ltd. , Tokyo, Japan.

ORCID-Profile: Jumpei Omi, Taiga Kato, Yohei Yoshihama, Koki Sawada, Nozomu Kono, Junken Aoki

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • Japan Science and Technology Agency Moonshot R&D Program

Zitieren

APA

Omi, J., Kato, T., Yoshihama, Y., Sawada, K., Kono, N., & Aoki, J. (2024). Phosphatidylserine synthesis controls oncogenic B cell receptor signaling in B cell lymphoma. Journal of Cell Biology. https://doi.org/10.1083/jcb.202212074

Vancouver

Omi J, Kato T, Yoshihama Y, Sawada K, Kono N, Aoki J. Phosphatidylserine synthesis controls oncogenic B cell receptor signaling in B cell lymphoma. Journal of Cell Biology. 2024. doi:10.1083/jcb.202212074

BibTeX
@article{Omi2024,
  author = {Omi, Jumpei and Kato, Taiga and Yoshihama, Yohei and Sawada, Koki and Kono, Nozomu and Aoki, Junken},
  title = {Phosphatidylserine synthesis controls oncogenic B cell receptor signaling in B cell lymphoma},
  journal = {Journal of Cell Biology},
  year = {2024},
  doi = {10.1083/jcb.202212074}
}
Kostenlos starten →